Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-21

FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ULORIC (febuxostat) from Takeda Pharmaceuticals America, Inc., reflecting an additional regulatory action for the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Uloric (febuxostat)

Snippet

SUPPL AP for ULORIC (FEBUXOSTAT)